Literature DB >> 19319981

Perinatal transmission of hepatitis C virus infection.

Giuseppe Indolfi1, Massimo Resti.   

Abstract

In industrialized countries, hepatitis C virus (HCV) is the most common cause of chronic liver disease in children. Perinatal transmission is the leading cause of infection. Perinatal transmission is confined almost always to women with detectable HCV ribonucleic acid (RNA) in the peripheral blood by the polymerase chain reaction but all children born to women with anti-HCV antibodies should be tested for HCV. Some but not all studies found that a high concentration of serum HCV RNA is associated with a higher risk of transmission. Maternal peripheral blood mononuclear cell infection by HCV, membrane rupture of longer than 6 hr before delivery, and procedures exposing the infant to maternal blood infected with HCV during vaginal delivery are associated with an increased risk of transmission. Maternal coinfection with HCV and human immunodeficiency virus, maternal history of intravenous drug use and of HCV infection of the sexual partner of the mother predict the risk of perinatal transmission and are dependent on the peripheral blood mononuclear cell infection by HCV. Delivery by Cesarean section is not recommended in pregnant women infected with HCV. Infected mothers can breast feed safely their infants if the nipples are not damaged. A previous delivery of a child infected perinatally with HCV does not increase the risk of transmission in subsequent pregnancies. Immunogenetic factors and HCV genotypes are not related to HCV perinatal transmission. Despite an increased understanding of the risk factors involved in perinatal transmission of HCV, to date little is known about the transmission mechanisms and timing. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19319981     DOI: 10.1002/jmv.21437

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  21 in total

1.  The human fetal immune response to hepatitis C virus exposure in utero.

Authors:  Jennifer M Babik; Deborah Cohan; Alexander Monto; Dennis J Hartigan-O'Connor; Joseph M McCune
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

2.  Seronegative hepatitis C virus infection in a child infected via mother-to-child transmission.

Authors:  Ariane Larouche; Geneviève Gaëtan; Nabil El-Bilali; Mathieu Quesnel-Vallières; Steven R Martin; Fernando Alvarez; Naglaa H Shoukry; Hugo Soudeyns
Journal:  J Clin Microbiol       Date:  2012-04-25       Impact factor: 5.948

3.  Perinatal transmission of hepatitis C virus in northern India.

Authors:  Ajit Sood; Vandana Midha; Manu Bansal; Neena Sood; Suman Puri; Amandeep Thara
Journal:  Indian J Gastroenterol       Date:  2012-02-24

Review 4.  KASL clinical practice guidelines: management of hepatitis C.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

Review 5.  Vertical transmission of hepatitis C virus: Current knowledge and perspectives.

Authors:  Chun-Yan Yeung; Hung-Chang Lee; Wai-Tao Chan; Chun-Bin Jiang; Szu-Wen Chang; Chih-Kuang Chuang
Journal:  World J Hepatol       Date:  2014-09-27

Review 6.  Hidden hazards of HCV transmission.

Authors:  Robério Amorim de Almeida Pondé
Journal:  Med Microbiol Immunol       Date:  2010-05-12       Impact factor: 3.402

Review 7.  New treatments for chronic hepatitis C: an overview for paediatricians.

Authors:  Daniele Serranti; Giuseppe Indolfi; Massimo Resti
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

Review 8.  Hepatitis C virus in pregnancy.

Authors:  Mona R Prasad; Jonathan R Honegger
Journal:  Am J Perinatol       Date:  2013-02-06       Impact factor: 1.862

9.  Hepatic and extra-hepatic sequelae, and prevalence of viral hepatitis C infection estimated from routine data in at-risk groups.

Authors:  Annunziata Faustini; Paola Colais; Emanuele Fabrizi; Anna Maria Bargagli; Marina Davoli; Domenico Di Lallo; Anteo Di Napoli; Patrizio Pezzotti; Chiara Sorge; Rita Grillo; Carla Maresca; Olga Recchia; Carlo A Perucci
Journal:  BMC Infect Dis       Date:  2010-04-19       Impact factor: 3.090

10.  Polymorphisms in the IFNL3/IL28B gene and hepatitis C: from adults to children.

Authors:  Giuseppe Indolfi; Chiara Azzari; Massimo Resti
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.